A ₹2,160 crore NHAI highway project in Bihar is secured by a Ceigall India subsidiary; trading activity is seen in the stock.
Ceigall India’s wholly owned subsidiary, Ceigall Infra Projects Private Limited, has been revealed as the L1 bidder for a ₹2,160 crore National Highways Authority of India (NHAI) tender to four-lane a highway in the state of Bihar. The venture will take place in the Hybrid Annuity Mode (HAM) manner for…
Despite an increase in volume, Dalmia Bharat gets downgraded to “HOLD” after the third quarter; the stock is trading close to ₹2,220.
Dalmia Bharat reported its Q3 FY26 results wherein sales volume increased 9.5% YoY at 7.3 MnT, while EBITDA grew 17.8% YoY at ₹602 crore. In contrast, it witnesses a decrease in net sales realization by 4% QoQ due to pressure on prices and escalations. Consequently, Prabhudas Lilladher downgraded the stock…
Zydus Lifesciences Expands Access to Oncology by Introducing the World’s First Nivolumab Biosimilar in India
Zydus Lifesciences Limited announced the launch of Tishtha™, the world’s first biosimilar for the cancer immunotherapy drug Nivolumab, in India on January 22, 2026. This is targeted at dramatically improving access to advanced oncology treatments by making the therapy available at approximately one-fourth the cost of the reference drug. The…
India’s Coal Growth Is Delayed as Renewables Grow, Reflecting the World’s Energy Transition
The ambitious target of coal-fired power projects in India is running into operational and investment challenges, with only a small portion of the projects being realized. This is being faced at a time when renewable energy sources, especially solar energy, appear to be rapidly increasing in power generation, enough to…
